Cazzaniga G - Search Results

1

Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.

Lutz C, Woll PS, Hall G, Castor A, Dreau H, Cazzaniga G, Zuna J, Jensen C, Clark SA, Biondi A, Mitchell C, Ferry H, Schuh A, Buckle V, Jacobsen SW, Enver T. Lutz C, et al. Among authors: cazzaniga g. Leukemia. 2013 Apr;27(5):1204-1207. doi: 10.1038/leu.2012.306. Epub 2012 Oct 22. Leukemia. 2013. PMID: 23086103 Free PMC article. No abstract available.

2

Monitoring minimal residual disease using chromosomal translocations in childhood ALL.

Cazzaniga G, Rossi V, Biondi A. Cazzaniga G, et al. Best Pract Res Clin Haematol. 2002 Mar;15(1):21-35. doi: 10.1053/beha.2002.0183. Best Pract Res Clin Haematol. 2002. PMID: 11987914 Review.

3

Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.

Carlotti E, Pettenella F, Amaru R, Slater S, Lister TA, Barbui T, Basso G, Cazzaniga G, Rambaldi A, Biondi A. Carlotti E, et al. Among authors: cazzaniga g. Br J Haematol. 2002 Sep;118(4):1011-8. doi: 10.1046/j.1365-2141.2002.03747.x. Br J Haematol. 2002. PMID: 12199779 Free article.

4

Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response.

Cazzaniga G, Lanciotti M, Rossi V, Di Martino D, Aricò M, Valsecchi MG, Basso G, Masera G, Micalizzi C, Biondi A. Cazzaniga G, et al. Br J Haematol. 2002 Nov;119(2):445-53. doi: 10.1046/j.1365-2141.2002.03838.x. Br J Haematol. 2002. PMID: 12406084 Free article.

5

FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.

Arrigoni P, Beretta C, Silvestri D, Rossi V, Rizzari C, Valsecchi MG, Cazzaniga G, Biondi A. Arrigoni P, et al. Among authors: cazzaniga g. Br J Haematol. 2003 Jan;120(1):89-92. doi: 10.1046/j.1365-2141.2003.04032.x. Br J Haematol. 2003. PMID: 12492581 Free article.

6

Results of minimal residual disease (MRD) evaluation and MRD-based treatment stratification in childhood ALL.

Cazzaniga G, d'Aniello E, Corral L, Biondi A. Cazzaniga G, et al. Best Pract Res Clin Haematol. 2002 Dec;15(4):623-38. doi: 10.1053/beha.2002.0228. Best Pract Res Clin Haematol. 2002. PMID: 12617867 Review.

7

Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.

Tosi S, Hughes J, Scherer SW, Nakabayashi K, Harbott J, Haas OA, Cazzaniga G, Biondi A, Kempski H, Kearney L. Tosi S, et al. Among authors: cazzaniga g. Genes Chromosomes Cancer. 2003 Oct;38(2):191-200. doi: 10.1002/gcc.10258. Genes Chromosomes Cancer. 2003. PMID: 12939747

8

Minimal residual disease as a surrogate marker for risk assignment to ALL patients.

Cazzaniga G, Gaipa G, Rossi V, Biondi A. Cazzaniga G, et al. Rev Clin Exp Hematol. 2003 Sep;7(3):292-323. Rev Clin Exp Hematol. 2003. PMID: 15024971 Review.

9

Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood.

Maia AT, Tussiwand R, Cazzaniga G, Rebulla P, Colman S, Biondi A, Greaves M. Maia AT, et al. Among authors: cazzaniga g. Genes Chromosomes Cancer. 2004 May;40(1):38-43. doi: 10.1002/gcc.20010. Genes Chromosomes Cancer. 2004. PMID: 15034866

10

Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology.

Cazzaniga G, Biondi A. Cazzaniga G, et al. Haematologica. 2005 Mar;90(3):382-90. Haematologica. 2005. PMID: 15749670 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters